Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|November 30, 2012
Supplements and Featured Publications
- New Approaches to Measuring Value in Oncology Therapy
- Volume 18
- Issue 11 Suppl
Appendix B -- Value of Survival Gains in Chronic Myeloid Leukemia
Advertisement
Articles in this issue
almost 14 years ago
eAppendix -- New Approaches to Measuring Value in Oncology Therapyalmost 14 years ago
Appendix A -- Value of Survival Gains in Chronic Myeloid Leukemiaalmost 14 years ago
Participating Faculty: New Approaches to Measuring Value in Oncology Therapyalmost 14 years ago
Dynamic Cost-Effectiveness of Oncology Drugsalmost 14 years ago
Value of Survival Gains in Chronic Myeloid LeukemiaAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
2
AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans
3
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
4
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
5